Staar Surgical Q2 2024 GAAP EPS $0.15 Beats $0.10 Estimate, Sales $99.005M Beat $95.202M Estimate
Portfolio Pulse from Benzinga Newsdesk
Staar Surgical (NASDAQ:STAA) reported Q2 2024 earnings of $0.15 per share, beating the analyst estimate of $0.10 by 50%. Sales were $99.005 million, surpassing the $95.202 million estimate. This represents a 25% increase in EPS and a 7.26% increase in sales compared to the same period last year.
August 07, 2024 | 8:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Staar Surgical reported strong Q2 2024 earnings, with EPS of $0.15 beating estimates by 50% and sales of $99.005 million exceeding expectations. This indicates robust financial performance and growth.
The significant beat on both EPS and sales estimates, along with year-over-year growth, suggests strong financial health and positive market sentiment. This is likely to drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100